Previous close | 0.1400 |
Open | 0.1800 |
Bid | 0.0000 |
Ask | 0.2000 |
Strike | 12.50 |
Expiry date | 2024-06-21 |
Day's range | 0.1400 - 0.1800 |
Contract range | N/A |
Volume | |
Open interest | 4 |
BOSTON, May 24, 2024--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present final STAR-0215 Phase 1a healthy subject data in an encore presentation at the upcoming Eastern Allergy Conference in Palm Beach, Florida on June 1, 2024.
BOSTON, May 23, 2024--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present two posters at the upcoming European Academy of Allergy and Clinical Immunology (EAACI) Congress in Valencia, Spain on June 1, 2024.
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...